BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19009277)

  • 1. In vivo study of HCV in mice with chimeric human livers.
    Kneteman NM; Toso C
    Methods Mol Biol; 2009; 510():383-99. PubMed ID: 19009277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus replication in mice with chimeric human livers.
    Mercer DF; Schiller DE; Elliott JF; Douglas DN; Hao C; Rinfret A; Addison WR; Fischer KP; Churchill TA; Lakey JR; Tyrrell DL; Kneteman NM
    Nat Med; 2001 Aug; 7(8):927-33. PubMed ID: 11479625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel HCV replication mouse model using human hepatocellular carcinoma xenografts.
    Guévin C; Lamarre A; Labonté P
    Antiviral Res; 2009 Oct; 84(1):14-22. PubMed ID: 19622372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro models for analysis of the hepatitis C virus life cycle.
    Aly HH; Shimotohno K; Hijikata M; Seya T
    Microbiol Immunol; 2012 Jan; 56(1):1-9. PubMed ID: 22145950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-human primate surrogate model of hepatitis C virus infection.
    Akari H; Iwasaki Y; Yoshida T; Iijima S
    Microbiol Immunol; 2009 Jan; 53(1):53-7. PubMed ID: 19161559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
    Raymond VA; Selliah S; Ethier C; Houle R; Jouan L; Maniere T; Lamarre D; Willems B; Bilodeau M
    Liver Int; 2009 Jul; 29(6):942-9. PubMed ID: 19302183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication of hepatitis C virus.
    Moradpour D; Penin F; Rice CM
    Nat Rev Microbiol; 2007 Jun; 5(6):453-63. PubMed ID: 17487147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental models for hepatitis C viral infection.
    Boonstra A; van der Laan LJ; Vanwolleghem T; Janssen HL
    Hepatology; 2009 Nov; 50(5):1646-55. PubMed ID: 19670425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV research and anti-HCV drug discovery: toward the next generation.
    Wakita T
    Adv Drug Deliv Rev; 2007 Oct; 59(12):1196-9. PubMed ID: 17905463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems.
    Gottwein JM; Bukh J
    Adv Virus Res; 2008; 71():51-133. PubMed ID: 18585527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal model for study of human hepatitis viruses.
    Chayama K; Hayes CN; Hiraga N; Abe H; Tsuge M; Imamura M
    J Gastroenterol Hepatol; 2011 Jan; 26(1):13-8. PubMed ID: 21175788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis C virus and its susceptibility to interferon.
    Hiraga N; Imamura M; Tsuge M; Noguchi C; Takahashi S; Iwao E; Fujimoto Y; Abe H; Maekawa T; Ochi H; Tateno C; Yoshizato K; Sakai A; Sakai Y; Honda M; Kaneko S; Wakita T; Chayama K
    FEBS Lett; 2007 May; 581(10):1983-7. PubMed ID: 17466983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studying HCV cell entry with HCV pseudoparticles (HCVpp).
    Bartosch B; Cosset FL
    Methods Mol Biol; 2009; 510():279-93. PubMed ID: 19009269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of inducible hepatitis C virus transgenic mouse lines.
    Ernst E; Schönig K; Bugert JJ; Bläker H; Pfaff E; Stremmel W; Encke J
    J Med Virol; 2007 Aug; 79(8):1103-12. PubMed ID: 17596832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV.
    Meuleman P; Leroux-Roels G
    Antiviral Res; 2008 Dec; 80(3):231-8. PubMed ID: 18706933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent contributions of in vitro models to our understanding of hepatitis C virus life cycle.
    Régeard M; Lepère C; Trotard M; Gripon P; Le Seyec J
    FEBS J; 2007 Sep; 274(18):4705-18. PubMed ID: 17824957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus virology and new treatment targets.
    Meier V; Ramadori G
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus (HCV) infection: a systemic disease.
    Craxì A; Laffi G; Zignego AL
    Mol Aspects Med; 2008; 29(1-2):85-95. PubMed ID: 18177700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes.
    Sugiyama M; Tanaka Y; Kurbanov F; Maruyama I; Shimada T; Takahashi S; Shirai T; Hino K; Sakaida I; Mizokami M
    Gastroenterology; 2009 Feb; 136(2):652-62.e3. PubMed ID: 19041311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A milestone for hepatitis C virus research: a virus generated in cell culture is fully viable in vivo.
    Bukh J; Purcell RH
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3500-1. PubMed ID: 16505349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.